BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21707848)

  • 1. Tumor-to-tumor metastasis: lung adenocarcinoma metastasizing to a follicular variant of papillary thyroid carcinoma.
    Hashimoto K; Yamamoto H; Nakano T; Oyama M; Shiratsuchi H; Nakashima T; Tamiya S; Komune S; Oda Y
    Pathol Int; 2011 Jul; 61(7):435-41. PubMed ID: 21707848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour-to-tumour metastasis from papillary thyroid carcinoma with BRAF mutation to lung adenocarcinoma with EGFR mutation: the utility of mutation-specific antibodies.
    Katsuya Y; Yoshida A; Watanabe S; Tsuta K
    Histopathology; 2015 Aug; 67(2):262-6. PubMed ID: 25556681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR mutation L747P led to gefitinib resistance and accelerated liver metastases in a Chinese patient with lung adenocarcinoma.
    Yu G; Xie X; Sun D; Geng J; Fu F; Zhang L; Wang H
    Int J Clin Exp Pathol; 2015; 8(7):8603-6. PubMed ID: 26339441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung adenocarcinoma and its thyroid metastasis characterized on fine-needle aspirates by cytomorphology, immunocytochemistry, and next-generation sequencing.
    Bellevicine C; Vigliar E; Malapelle U; Carelli E; Fiorelli A; Vicidomini G; Cappabianca S; Santini M; Troncone G
    Diagn Cytopathol; 2015 Jul; 43(7):585-9. PubMed ID: 25900221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastasis to the thyroid from lung adenocarcinoma mimicking thyroid carcinoma.
    Haraguchi S; Hioki M; Yamashita K; Orii K; Matsumoto K; Shimizu K
    Jpn J Thorac Cardiovasc Surg; 2004 Jul; 52(7):353-6. PubMed ID: 15296034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular Variant of Papillary Thyroid Cancer with Bilateral Renal Metastases Discovered Incidentally During Work-Up of Primary Endometrial Cancer: A Rare Occurrence.
    Lubana SS; Singh N; Tuli SS; Bashir T; Sachmechi I; Kemeny MM
    Am J Case Rep; 2015 Jul; 16():459-68. PubMed ID: 26181765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenocarcinoma of the lung with rare insertion mutation in EGFR exon 19 that had partial response to gefitinib: a case report.
    Kozlov V; Karpov I; Kovalenko S; Shamanin V
    Exp Oncol; 2017 Jul; 39(2):155-156. PubMed ID: 29483495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumonectomy after response to gefitinib treatment for lung adenocarcinoma.
    Funakoshi Y; Takeuchi Y; Maeda H
    Asian Cardiovasc Thorac Ann; 2013 Aug; 21(4):482-4. PubMed ID: 24570539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Unique, Heterozygous Germline Mutation, STK11 (p.F354L), in a Child with an Encapsulated Follicular Variant of Papillary Thyroid Carcinoma within Six Months of Completing Treatment for Neuroblastoma.
    Buryk MA; Picarsic JL; Creary SE; Shaw PH; Simons JP; Deutsch M; Monaco SE; Nikiforov YE; Witchel SF
    Pediatr Dev Pathol; 2015; 18(4):318-23. PubMed ID: 25751324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-to-tumor metastases: papillary thyroid carcinoma into a clear cell renal cell carcinoma.
    Song JS; Taylor SM; Trites J; Rigby MH; Bullock MJ; Merrimen J; Rendon R; Hart RD
    J Otolaryngol Head Neck Surg; 2017 Mar; 46(1):17. PubMed ID: 28249616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor mutations in synchronous recurrent lung cancer in an 82-year-old woman. A case story.
    Kristiansen C; Olsen KE; Hansen NC; Hansen KH; Hansen O
    Acta Oncol; 2012 Sep; 51(7):948-9. PubMed ID: 22471746
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of primary lung adenocarcinoma mimicking metastatic papillary thyroid carcinoma.
    Tanaka A; Okita R; Morishige T; Okada M; Inokawa H; Hirazawa K; Kameyama K; Ikeda A; Ikeda E
    Thorac Cancer; 2024 Feb; 15(4):353-357. PubMed ID: 38131508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can EGFR mutation status be reliably determined in pre-operative needle biopsies from adenocarcinomas of the lung?
    Lindahl KH; Sørensen FB; Jonstrup SP; Olsen KE; Loeschke S
    APMIS; 2015 Apr; 123(4):289-97. PubMed ID: 25556929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The salvage therapy in lung adenocarcinoma initially harbored susceptible EGFR mutation and acquired resistance occurred to the first-line gefitinib and second-line cytotoxic chemotherapy.
    Yang CJ; Hung JY; Tsai MJ; Wu KL; Liu TC; Chou SH; Lee JY; Hsu JS; Huang MS; Chong IW
    BMC Pharmacol Toxicol; 2017 May; 18(1):21. PubMed ID: 28486985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case report of thyroid cancer showing a remarkable effect of gefitinib.
    Matsumoto F; Itoh S; Ohba S; Ikeda K
    Auris Nasus Larynx; 2009 Oct; 36(5):623-6. PubMed ID: 19261404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of targeted next-generation sequencing with conventional sequencing for predicting the responsiveness to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy in never-smokers with lung adenocarcinoma.
    Han JY; Kim SH; Lee YS; Lee SY; Hwang JA; Kim JY; Yoon SJ; Lee GK
    Lung Cancer; 2014 Aug; 85(2):161-7. PubMed ID: 24857785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podoplanin-positive cancer-associated fibroblasts in the tumor microenvironment induce primary resistance to EGFR-TKIs in lung adenocarcinoma with EGFR mutation.
    Yoshida T; Ishii G; Goto K; Neri S; Hashimoto H; Yoh K; Niho S; Umemura S; Matsumoto S; Ohmatsu H; Iida S; Niimi A; Nagai K; Ohe Y; Ochiai A
    Clin Cancer Res; 2015 Feb; 21(3):642-51. PubMed ID: 25388165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: small cell transformation and metastasis to the breast in a patient with lung adenocarcinoma following maintenance treatment with epidermal growth factor receptor tyrosine kinase inhibitors.
    Lin Q; Cai GP; Yang KY; Yang L; Chen CS; Li YP
    BMC Cancer; 2016 Aug; 16():593. PubMed ID: 27488410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metastatic carcinoma of the sigmoid colon to the thyroid gland].
    Shibutani Y; Inoue D; Yokota T; Okuda J; Mori T
    Nihon Naibunpi Gakkai Zasshi; 1992 Aug; 68(8):765-72. PubMed ID: 1397385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase II Study of Poziotinib in Patients with Epidermal Growth Factor Receptor (
    Han JY; Lee KH; Kim SW; Min YJ; Cho E; Lee Y; Lee SH; Kim HY; Lee GK; Nam BH; Han H; Jung J; Lee JS
    Cancer Res Treat; 2017 Jan; 49(1):10-19. PubMed ID: 27188206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.